
Gameto is a biotechnology company focused on improving women’s reproductive health through advanced cell engineering. What makes Gameto unique is its approach to recreating natural ovarian functions to make fertility treatments safer, shorter, and more effective. By developing therapies that span infertility, ovarian health, and menopause, Gameto aims to support women across their entire reproductive lifespan.

Investment Details
Funding Round
Series C
Milestones
Funded in 2025

About the Founder
Dr. Dina Radenkovic
Dr. Dina Radenkovic is the co-founder and CEO of Gameto, leading the vision to transform women’s health and fertility care. Her work focuses on innovations like Fertilo to make IVF faster, less invasive, and more accessible.
Real Investors. Real Outcomes.
Start Your Investing Journey with Portfolia
Our live overview sessions are the best way to experience how Portfolia is transforming venture capital and why the experience is unmatched.
- MEET OUR PARTNERS
- LEARN HOW OUR FUNDS WORK
- SEE THE COMPANIES WE'RE BACKING.


